Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 44.58% is in line with its 5-year average of 48.02%, near the high end of its 5-year range (-13.80%–65.06%).
As of the fiscal period ended Tuesday, March 31, 2026. 8.31% below its 12-month average of 48.62%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
44.58%
EBITDA MARGIN AVG TTM
48.62%
EBITDA MARGIN AVG 3Y
50.67%
EBITDA MARGIN AVG 5Y
51.11%
EBITDA MARGIN AVG 10Y
52.06%
EBITDA MARGIN AVG 15Y
50.18%
EBITDA MARGIN AVG 20Y
39.83%
CURRENT VS TTM AVG
-8.31%
CURRENT VS 3Y AVG
-12.02%
CURRENT VS 5Y AVG
-12.78%
CURRENT VS 10Y AVG
-14.36%
CURRENT VS 15Y AVG
-11.15%
CURRENT VS 20Y AVG
+11.93%
United Therapeutics Corporation
Market Cap
$21.92B
EBITDA Margin
44.58%
TTM Avg
48.62%
3Y Avg
50.67%
5Y Avg
51.11%
Market Cap
$21.88B
EBITDA Margin
-147.07%
TTM Avg
-132.24%
3Y Avg
-66.39%
5Y Avg
-46.73%
Market Cap
$24.01B
EBITDA Margin
27.93%
TTM Avg
16.21%
3Y Avg
17.95%
5Y Avg
14.24%
Market Cap
$24.43B
EBITDA Margin
34.73%
TTM Avg
34.58%
3Y Avg
34.05%
5Y Avg
33.84%
Market Cap
$24.50B
EBITDA Margin
24.13%
TTM Avg
25.03%
3Y Avg
27.36%
5Y Avg
27.53%
Market Cap
$18.76B
EBITDA Margin
29.84%
TTM Avg
29.78%
3Y Avg
28.27%
5Y Avg
25.91%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $21.92B | 44.58% | 48.62% | 50.67% | 51.11% |
| Moderna, Inc. (MRNA)vs › | $21.88B | -147.07% | -132.24% | -66.39% | -46.73% |
| STERIS plc (STE)vs › | $22.67B | 26.76% | 25.68% | 26.35% | 25.75% |
| Viatris Inc. (VTRS)vs › | $20.53B | 0.95% | 10.32% | 17.98% | 18.96% |
| BioNTech SE (BNTX)vs › | $23.33B | -9.29% | -23.11% | 12.60% | 20.38% |
| Incyte Corporation (INCY)vs › | $24.01B | 27.93% | 16.21% | 17.95% | 14.24% |
| Waters Corporation (WAT)vs › | $24.43B | 34.73% | 34.58% | 34.05% | 33.84% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.50B | 24.13% | 25.03% | 27.36% | 27.53% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.76B | 29.84% | 29.78% | 28.27% | 25.91% |
| Labcorp Holdings Inc. (LH)vs › | $25.21B | 15.75% | 14.53% | 14.10% | 17.90% |
Gross Margin
86.6%
EBITDA Margin
44.6%
Operating Margin
45.3%
Net Margin
40.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 44.58% |
| 2025-12-31 | 48.13% |
| 2025-09-30 | 51.43% |
| 2025-06-30 | 48.28% |
| 2025-03-31 | 50.68% |
| 2024-12-31 | 51.28% |
| 2024-09-30 | 48.36% |
| 2024-06-30 | 47.36% |
| 2024-03-31 | 54.79% |
| 2023-12-31 | 44.54% |
| 2023-09-30 | 55.84% |
| 2023-06-30 | 54.70% |
| 2023-03-31 | 58.73% |
| 2022-12-31 | 38.41% |
| 2022-09-30 | 63.41% |
| 2022-06-30 | 45.94% |
| 2022-03-31 | 65.06% |
| 2021-12-31 | 43.93% |
| 2021-09-30 | 54.22% |
| 2021-06-30 | 52.54% |
| 2021-03-31 | -13.80% |
| 2020-12-31 | 20.37% |
| 2020-09-30 | 61.27% |
| 2020-06-30 | 42.29% |
| 2020-03-31 | 50.27% |
| 2019-12-31 | 24.43% |
| 2019-09-30 | 48.84% |
| 2019-06-30 | 62.04% |
| 2019-03-31 | -178.05% |
| 2018-12-31 | 37.23% |
| 2018-09-30 | 38.53% |
| 2018-06-30 | 50.73% |
| 2018-03-31 | 80.88% |
| 2017-12-31 | 31.57% |
| 2017-09-30 | 74.41% |
| 2017-06-30 | 21.64% |
| 2017-03-31 | 73.28% |
| 2016-12-31 | 44.50% |
| 2016-09-30 | 60.46% |
| 2016-06-30 | 71.04% |
| 2016-03-31 | 100.65% |
| 2015-12-31 | 40.26% |
| 2015-09-30 | 102.36% |
| 2015-06-30 | 51.87% |
| 2015-03-31 | -1.98% |
| 2014-12-31 | 54.14% |
| 2014-09-30 | -7.31% |
| 2014-06-30 | 56.99% |
| 2014-03-31 | 77.30% |
| 2013-12-31 | -7.18% |
| 2013-09-30 | 37.16% |
| 2013-06-30 | 46.32% |
| 2013-03-31 | 41.69% |
| 2012-12-31 | 55.74% |
| 2012-09-30 | 36.14% |
| 2012-06-30 | 49.60% |
| 2012-03-31 | 55.52% |
| 2011-12-31 | 35.05% |
| 2011-09-30 | 53.52% |
| 2011-06-30 | 76.46% |
| 2011-03-31 | 25.78% |
| 2010-12-31 | 7.68% |
| 2010-09-30 | 39.13% |
| 2010-06-30 | 47.57% |
| 2010-03-31 | 28.57% |
| 2009-12-31 | 2.33% |
| 2009-09-30 | 14.65% |
| 2009-06-30 | -2.05% |
| 2009-03-31 | 28.01% |
| 2008-12-31 | -173.31% |
| 2008-09-30 | 25.41% |
| 2008-06-30 | 27.70% |
| 2008-03-31 | 25.76% |
| 2007-12-31 | -13.35% |
| 2007-09-30 | 24.19% |
| 2007-06-30 | 16.02% |
| 2007-03-31 | -18.26% |
| 2006-12-31 | 7.80% |
| 2006-09-30 | 29.29% |
| 2006-06-30 | 29.86% |
| 2006-03-31 | 9.11% |
| 2005-12-31 | 37.02% |
| 2005-09-30 | 45.83% |
| 2005-06-30 | 39.18% |
| 2005-03-31 | 32.01% |
| 2004-12-31 | 32.06% |
| 2004-09-30 | 31.38% |
| 2004-06-30 | 22.25% |
| 2004-03-31 | -13.07% |
| 2003-12-31 | -21.21% |
| 2003-09-30 | -7.81% |
| 2003-06-30 | -15.95% |
| 2003-03-31 | -27.13% |
| 2002-12-31 | -21.82% |
| 2002-09-30 | -116.42% |
| 2002-06-30 | -2.81% |
